ask="40.00"
ask_size="100"
average_daily_volume="340160"
bid="N/A"
bid_size="N/A"
book_value="3.58"
change="+0.53"
change_from_200_day_moving_average="6.40"
change_from_50_day_moving_average="5.05"
change_from_52_week_high="-3.69"
change_From_52_week_low="21.60"
change_in_percent="+1.55%"
close="34.64"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.46"
ebitda="-65.10M"
eps_estimate_current_year="-2.74"
eps_estimate_next_quarter="-0.79"
eps_estimate_next_year="-4.07"
ex_dividend_date="N/A"
float_shares="18345000"
high="34.89"
high_52_weeks="38.33"
last_trade_date="1/27/2017"
last_trade_price="34.64"
last_trade_size="8532"
last_trade_time="4:00pm"
low="34.04"
low_52_weeks="13.04"
market_capitalization="945.43M"
moving_average_200_day="28.24"
moving_average_50_day="29.59"
name="Blueprint Medicines Corporation"
notes="N/A"
one_year_target_price="37.33"
open="34.04"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+22.67%"
percent_change_from_50_day_moving_average="+17.07%"
percent_change_from_52_week_high="-9.63%"
percent_change_from_52_week_low="+165.64%"
previous_close="34.11"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="9.53"
price_per_sales="37.67"
revenue="24.72M"
shares_outstanding="27293000"
short_ratio="5.25"
stock_exchange="NMS"
symbol="BPMC"
volume="206943"
weeks_range_52="13.04 - 38.33"
